Selexys Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Oklahoma City, OK and active since 2004.
Selexys Pharmaceuticals was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Scott Rollins, Other at the company’s single location by writing to 840 Research Parkway, Oklahoma City, Oklahoma OK 73104 or by phoning (405) 319-8195. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Selexys Pharmaceuticals |
| Contact Person: | Scott Rollins, Other |
| Address: | 840 Research Parkway, Oklahoma City, Oklahoma 73104 |
| Phone Number: | (405) 319-8195 |
| Website Address: | selexys.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 5417115 |
| Share This Business: |
Selexys Pharmaceuticals was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Scott Rollins, Other for inquiries that concern Selexys Pharmaceuticals by calling the company number (405) 319-8195, as your correspondence is most welcome. Additionally, the physical location of the single location of Selexys Pharmaceuticals can be found at the coordinates 35.47499,-97.50428 as well as the street address 840 Research Parkway in Oklahoma City, Oklahoma 73104.
For its online presence, you may visit Selexys Pharmaceuticals’s website at selexys.com and engage with its social media outlets through on Twitter and on Facebook.